Cortica, a telepsychiatry platform specializing in autism spectrum disorders, has raised an additional USD 40 million in a Series D extension, bringing the total Series D funding round to USD 115 million. CVS Health Ventures led the round, along with LRVHealth, Ascension Investment Management, and the University of Wisconsin Foundation, among other investors.
The additional funding will support the nationwide expansion of Cortica's autism care model and investments in technology, data capture, research, and enhancement of the clinician and patient experience.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.